TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8016791

Group type: COMPARATOR
Intervention: MDI alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Volumatic spacer
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bricanyl Spacer
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebuhaler
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Open mouth technique
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 10
Study: 2562233

Group type: EXPERIMENTAL
Intervention: Magnesium valproate (MV) 1200 mg daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Magnesium valproate (MV) 400 mg single dose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Long-term therapy with magnesium valproate (MV)
Number of subjects: 8
Study: 50110

Group type: EXPERIMENTAL
Intervention: Dicynene
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 29538243

Group type: EXPERIMENTAL
Intervention: Bone-anchored annular closure device (ACD)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Limited lumbar discectomy only (Controls)
Number of subjects: 550
Study: 27513406

Group type: COMPARATOR
Intervention: 0 cmH2O PEEP
Number of subjects: 75

Group type: COMPARATOR
Intervention: 5 cmH2O PEEP
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 8 cmH2O PEEP
Number of subjects: 75
Study: 23701571

Group type: EXPERIMENTAL
Intervention: Fruit-juice drink (FJD) with 500 mL
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo drink (HFM-P)
Number of subjects: 15
Study: 22868522

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol combination (BUD/FM) 320/9 μg/day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Budesonide plus tulobuterol patch (BUD + Tulo)
Number of subjects: 17
Study: 20602006

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (AEP) on a treadmill, 3 times a week for two months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sedentary behavior (Control Group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (AEP)
Number of subjects: 10
Study: 18391102

Group type: EXPERIMENTAL
Intervention: Environmental tobacco smoke (ETS) exposure for 1 hour
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nontobacco smoke exposure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sublingual administration of nicotine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: ETS exposure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both ETS and nontobacco smoke exposure
Number of subjects: 11
Study: 15662072

Group type: EXPERIMENTAL
Intervention: Audio prompts during CPR
Number of subjects: 24

Group type: COMPARATOR
Intervention: No audio prompts during CPR
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Audio prompts before training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: After training
Number of subjects: 24
Study: 12819247

Group type: EXPERIMENTAL
Intervention: High-dose dialysis
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Standard-dose dialysis
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: High-flux dialysis membrane
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Low-flux dialysis membrane
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Co-morbidity score
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Vascular access-related infection
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Non-access-related infection
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Catheters in patients with access-related infection
Number of subjects: 1846
Study: 10719135

Group type: EXPERIMENTAL
Intervention: Cobalamin level
Number of subjects: 159
Study: 8799541

Group type: EXPERIMENTAL
Intervention: Microsurgical discectomy (MS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard lumbar discectomy (SD)
Number of subjects: 79
Study: 1346170

Group type: EXPERIMENTAL
Intervention: Protocol group (pHi-guided therapy)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (standard ICU practices)
Number of subjects: 260
Study: 3883737

Group type: COMPARATOR
Intervention: Molsidomine 2 or 4 mg single oral dose
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Molsidomine 8 to 24 mg/24 hours
Number of subjects: 23
Study: 31408030

Group type: EXPERIMENTAL
Intervention: Microbicide candidates (various dosing mechanisms including vaginal gel, oral tablet, ring)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 30175792

Group type: EXPERIMENTAL
Intervention: Xanthan Gum (XG) added to enteral nutrient Meibalance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Meibalance without XG)
Number of subjects: 0
Study: 26572722

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (traditional pharmacological approaches)
Number of subjects: 0
Study: 25037750

Group type: EXPERIMENTAL
Intervention: P-36/eCG
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: P-36/LH2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: P-36/LH4
Number of subjects: 25

Group type: COMPARATOR
Intervention: P-36 (control)
Number of subjects: 25
Study: 23206451

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (steady-state)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Digoxin (steady-state)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Atorvastatin (steady-state)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All drugs (alone or in combination)
Number of subjects: 36
Study: 20575725

Group type: EXPERIMENTAL
Intervention: Automated review group
Number of subjects: 938

Group type: COMPARATOR
Intervention: Manual nurse review (control) group
Number of subjects: 938
Study: 19102132

Group type: EXPERIMENTAL
Intervention: CPAP group
Number of subjects: 0

Group type: COMPARATOR
Intervention: non-CPAP group
Number of subjects: 0
Study: 16048137

Group type: EXPERIMENTAL
Intervention: 25 hydroxyvitamin D3 [25(OH)D], 50 microg twice a week for 14 days (Study 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin D3 800 IU (20 microg) daily for 12 months (Study 2)
Number of subjects: 50
Study: 11993510

Group type: EXPERIMENTAL
Intervention: Combination therapy (sulfasalazine and azathioprine)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sulfasalazine monotherapy (placebo)
Number of subjects: 35
Study: 10515399

Group type: EXPERIMENTAL
Intervention: Breathing against a constant inspiratory resistance to task failure
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Determination of 12‐min sustained ventilatory capacity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Spirometric and maximal inspiratory and expiratory mouth pressure measurements
Number of subjects: 12
Study: 8534781

Group type: EXPERIMENTAL
Intervention: Theophylline (loading dose 5 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine (loading dose 10 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control healthy untreated prematures
Number of subjects: 20
Study: 1940223

Group type: EXPERIMENTAL
Intervention: IgM ELISA test
Number of subjects: 100

Group type: COMPARATOR
Intervention: Indirect haemagglutination test (IHA)
Number of subjects: 100
Study: 6818516

Group type: EXPERIMENTAL
Intervention: Sodium Valproate (DA)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (PH)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (PO)
Number of subjects: 69
Study: 30640970

Group type: EXPERIMENTAL
Intervention: Normal IOP (no suction cup)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IOP increased by 10 mm Hg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IOP increased by 20 mm Hg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Higher IOP
Number of subjects: 18
Study: 27798526

Group type: EXPERIMENTAL
Intervention: Minigrant program to increase physical activity (PA) among youth
Number of subjects: 800
Study: 25973526

Group type: EXPERIMENTAL
Intervention: MNTX (8 mg or 12 mg by body weight, administered every other day for two weeks)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo (administered every other day for two weeks)
Number of subjects: 116
Study: 24172161

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 and 20 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22859237

Group type: EXPERIMENTAL
Intervention: Alefacept 15 mg intramuscularly once weekly for 12 weeks plus nbUVB three times weekly
Number of subjects: 98

Group type: COMPARATOR
Intervention: Alefacept 15 mg intramuscularly once weekly for 12 weeks
Number of subjects: 98
Study: 19772184

Group type: EXPERIMENTAL
Intervention: Zotaline (test product)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zoloft (reference product)
Number of subjects: 24
Study: 17594251

Group type: EXPERIMENTAL
Intervention: Case managed intervention
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Preparation stage at baseline
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Support from someone (friend, family, social worker)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Diagnosis within 6 months of enrollment
Number of subjects: 273
Study: 15226169

Group type: EXPERIMENTAL
Intervention: Chinese herbal medications
Number of subjects: 45

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 45
Study: 12587480

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (GIK) solution
Number of subjects: 34

Group type: COMPARATOR
Intervention: Ringer solution
Number of subjects: 34
Study: 9822095

Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha-tocopherol acetate, 300 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9690924

Group type: EXPERIMENTAL
Intervention: Intervention group (27 patients)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (52 patients)
Number of subjects: 79
Study: 1812902

Group type: EXPERIMENTAL
Intervention: Aquafresh Flex toothbrush (soft, medium, firm bristle versions)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard brush with soft bristles (control)
Number of subjects: 35
Study: 6342546

Group type: EXPERIMENTAL
Intervention: clemastine
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 31580931

Group type: EXPERIMENTAL
Intervention: Acute psychosocial stressor (n=37)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-stress active control (n=17)
Number of subjects: 54
Study: 31525613

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention program (PIP) consisting of 12 weekly group sessions.
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard practice (control group).
Number of subjects: 194
Study: 28121265

Group type: EXPERIMENTAL
Intervention: Beta-Alanine (6.4g∙day‐1 for six weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Beta-Alanine
Number of subjects: 15
Study: 27500675

Group type: EXPERIMENTAL
Intervention: High-frequency intrapulmonary ventilation along with mineral water baths, inhalations, exercise therapy, manual massage, intake of extract maral root, and 'Yantar antiox' preparation.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard rehabilitative treatment without high-frequency intrapulmonary ventilation.
Number of subjects: 49
Study: 24894392

Group type: EXPERIMENTAL
Intervention: Superimposed electrical stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Voluntary contraction
Number of subjects: 8
Study: 23265079

Group type: EXPERIMENTAL
Intervention: 2-Hz violet laser acupuncture
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 100-Hz violet laser acupuncture
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 2-Hz and 100-Hz violet laser acupuncture
Number of subjects: 13
Study: 19939380

Group type: EXPERIMENTAL
Intervention: Type 1 female condom
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 2 female condom
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both types of female condoms
Number of subjects: 0
Study: 17564852

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) classroom
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal control
Number of subjects: 20
Study: 15817723

Group type: EXPERIMENTAL
Intervention: Glycerol ingestion (GI) - 37 ml water/l total body water plus 1.5 g glycerol/l total body water
Number of subjects: 7

Group type: COMPARATOR
Intervention: Water ingestion (WI) - 37 ml water/l total body water
Number of subjects: 7
Study: 11790937

Group type: EXPERIMENTAL
Intervention: Atrial pacing from the high right atrium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pacing from novel sites (interatrial septum, Bachman bundle, dual-site or biatrial pacing)
Number of subjects: 0
Study: 9345118

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 25443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25443
Study: 8877198

Group type: EXPERIMENTAL
Intervention: Enhanced computerized tomography (CT) with 18G needle aspiration
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3-point permucosal 18G needle aspirations
Number of subjects: 40
Study: 10277393

Group type: EXPERIMENTAL
Intervention: Organizational manipulations including reduced nurses' responsibility for management of patient flow and inclusion of an education checklist in the medical record
Number of subjects: 0
Study: 30149898

Group type: EXPERIMENTAL
Intervention: RMI (>200) in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: ROMA (≥29.9) in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: CA125 (>35 U/mL) in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: HE4 (>140 pmol/L) in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: RMI in premenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: ROMA (≥11.6) in premenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: CA125 in premenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: HE4 (>70 pmol/L) in premenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: RMI in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: ROMA in postmenopausal women
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: ROMA in premenopausal women
Number of subjects: 638
Study: 26123137

Group type: EXPERIMENTAL
Intervention: UFT 400 mg/d (n=61)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Surgery alone (n=56)
Number of subjects: 117
Study: 24971988

Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 2064

Group type: COMPARATOR
Intervention: No treatment with GnRH agonists
Number of subjects: 2064
Study: 22695211

Group type: EXPERIMENTAL
Intervention: Nicorette(®) Freshmint Gum
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nicorette(®) Microtab (tablet)
Number of subjects: 200
Study: 20157322

Group type: EXPERIMENTAL
Intervention: Family-based behavioral treatment (intervention)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 192
Study: 18310554

Group type: EXPERIMENTAL
Intervention: Proxy consent for clinical trial enrollment (simvastatin treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decision-making process for enrollment in a randomized controlled trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research enrollment decisions made by study partners
Number of subjects: 0
Study: 15976500

Group type: EXPERIMENTAL
Intervention: Family Support Organiser (FSO) service
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 340
Study: 12808261

Group type: EXPERIMENTAL
Intervention: 15% or greater reduction in total cholesterol
Number of subjects: 4615

Group type: EXPERIMENTAL
Intervention: Cholesterol levels below 240 mg/dl (6.20 mmol/L)
Number of subjects: 4615

Group type: EXPERIMENTAL
Intervention: Cholesterol levels below 220 mg/dl (5.68 mmol/L)
Number of subjects: 4615
Study: 10818892

Group type: EXPERIMENTAL
Intervention: Mattress 1 (specific mattress not named)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lloyd Davies position
Number of subjects: 25

Group type: COMPARATOR
Intervention: All mattresses
Number of subjects: 25
Study: 8674171

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Both PTCA and CABG
Number of subjects: 1011
Study: 1614112

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (Praxilène)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 6734389

Group type: EXPERIMENTAL
Intervention: Cooked Potato
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Raw Potato
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cooked Carrot
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Raw Carrot
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 10
Study: 31867724

Group type: EXPERIMENTAL
Intervention: TUN+CTG (test group; n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: CAF+CTG (control group; n=19)
Number of subjects: 39
Study: 28817437

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy followed by gastrectomy with D1+ lymphadenectomy
Number of subjects: 636
Study: 26932132

Group type: EXPERIMENTAL
Intervention: Mental Fitness intervention
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 65
Study: 24622150

Group type: EXPERIMENTAL
Intervention: Cognitive performance tests including episodic memory, numeracy, and a modified version of the Mini-Mental State Examination
Number of subjects: 1451

Group type: EXPERIMENTAL
Intervention: Models controlling for education, health status, and social and economic activity
Number of subjects: 1451
Study: 22077962

Group type: EXPERIMENTAL
Intervention: 1% WBI-1001 cream applied twice daily for 12 weeks
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 1% WBI-1001 cream
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 20550840

Group type: EXPERIMENTAL
Intervention: ABC (Activity Bursts in the Classroom) for Fitness program
Number of subjects: 5
Study: 17659065

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 117
Study: 16271652

Group type: EXPERIMENTAL
Intervention: IMPACT collaborative care program
Number of subjects: 450

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 450
Study: 11863301

Group type: EXPERIMENTAL
Intervention: Aspirin treatment (400 mg, one dose daily for 3 days, starting 12 hours before the flight)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) (one dose of enoxaparin injected between 2 and 4 hours before the flight, weight-adjusted 1,000 IU per 10 kg of body weight)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 300
Study: 10215215

Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (37 degrees C)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (25 degrees C)
Number of subjects: 79
Study: 7877544

Group type: EXPERIMENTAL
Intervention: Pravastatin (20‐40 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 2227075

Group type: EXPERIMENTAL
Intervention: Intravenous doxofylline (100 mg as a single dose over 10 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral doxofylline (400 mg given twice daily for 5 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 14
Study: 1036709

Group type: EXPERIMENTAL
Intervention: 50 mg raubasin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 500 mg bencyclan
Number of subjects: 30

Group type: COMPARATOR
Intervention: salt solution (placebo)
Number of subjects: 30
Study: 30171497

Group type: EXPERIMENTAL
Intervention: Tipifarnib 300 mg twice daily plus Erlotinib 150 mg once daily
Number of subjects: 27
Study: 29565149

Group type: EXPERIMENTAL
Intervention: Whole milk (300 Kcals; G1) daily for 23 weeks
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Fortified milk (300 Kcals; G2) daily for 23 weeks
Number of subjects: 328
Study: 25486372

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavior Therapy (CBT)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Sertraline (SRT)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Combination of CBT and Sertraline (COMB)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Pill Placebo (PBO)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Relaxation Training
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Exposure Tasks
Number of subjects: 488
Study: 23759749

Group type: EXPERIMENTAL
Intervention: HIV-LIPO-5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20823726

Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (STPP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study: 18788656

Group type: EXPERIMENTAL
Intervention: Eszopiclone 3 mg
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 15920183

Group type: EXPERIMENTAL
Intervention: Dartmouth Operative Conditions Scale (DOCS)
Number of subjects: 70
Study: 12886915

Group type: EXPERIMENTAL
Intervention: Intra-operative music
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Postoperative music
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (white noise)
Number of subjects: 151
Study: 10229289

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Switch to insulin therapy
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Hyperglycaemic complaints at baseline
Number of subjects: 94
Study: 8947995

Group type: EXPERIMENTAL
Intervention: Oral lithium carbonate (mean daily dose 437 +/- 185 mg, range 150-900 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral lithium carbonate
Number of subjects: 11